Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenghai Duan

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Journal of the National Cancer Institute|October 19, 2014
Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examinationDavid S Gierada, Paul Pinsky, Hrudaya Nath, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 20, 2026
Pulmonary Obstruction and Age, Not Activity, Associate With Muscle Oxidative Impairment in Smokers With and Without COPDAlessandra Adami, Fenghai Duan, Robert A Calmelat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235Stephanie Markovina, Fenghai Duan, Bradley S Snyder, et al.
Clinical Imaging|May 21, 2016
Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening TrialBarbara L McComb, Reginald F Munden, Fenghai Duan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 16, 2021
Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening TrialDae Hee Han, Fenghai Duan, Yanning Wu, et al.
Radiology|November 23, 2021
Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung CancerHamid Chalian, Holman Page McAdams, Youkyung Lee, et al.
Clinical Nuclear Medicine|December 23, 2022
Impact of Neck PET/CT Positivity on Survival Outcomes-Visual and Quantitative Assessment: Results From ACRIN 6685Brendan C Stack, Fenghai Duan, Justin Romanoff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Journal of the National Cancer Institute|October 19, 2014
Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examinationDavid S Gierada, Paul Pinsky, Hrudaya Nath, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 20, 2026
Pulmonary Obstruction and Age, Not Activity, Associate With Muscle Oxidative Impairment in Smokers With and Without COPDAlessandra Adami, Fenghai Duan, Robert A Calmelat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Regional Lymph Node Uptake of [(18)F]Fluorodeoxyglucose After Definitive Chemoradiation Therapy Predicts Local-Regional Failure of Locally Advanced Non-Small Cell Lung Cancer: Results of ACRIN 6668/RTOG 0235Stephanie Markovina, Fenghai Duan, Bradley S Snyder, et al.
Clinical Imaging|May 21, 2016
Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening TrialBarbara L McComb, Reginald F Munden, Fenghai Duan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 16, 2021
Clinical Significance of Lung-RADS Category 3 Lesions in the National Lung Screening TrialDae Hee Han, Fenghai Duan, Yanning Wu, et al.
Radiology|November 23, 2021
Mediastinal Lymphadenopathy in the National Lung Screening Trial (NLST) Is Associated with Interval Lung CancerHamid Chalian, Holman Page McAdams, Youkyung Lee, et al.
Clinical Nuclear Medicine|December 23, 2022
Impact of Neck PET/CT Positivity on Survival Outcomes-Visual and Quantitative Assessment: Results From ACRIN 6685Brendan C Stack, Fenghai Duan, Justin Romanoff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2014
Impact of 18F-fluoride PET in patients with known prostate cancer: initial results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 14, 2014
Impact of (18)F-Fluoride PET on Intended Management of Patients with Cancers Other Than Prostate Cancer: Results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Pageof 8